ArticleDrugs & therapy perspectives : for rational drug selection and use2021
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems.
Article in Drugs & therapy perspectives : for rational drug selection and use, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- Vaccine hesitancy in context of COVID-19 in East Africa: systematic review and meta-analysis.BMC public health · 2024Pooled it
- Optimal Management of the Public and Patients by Pharmacists in the Era of COVID-19: An Evidence-Based Review and Practical Recommendations.Frontiers in public health · 2021Pooled it
- Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV: a cohort study.BMC public health · 2025Article
- Vaccination Coverage Covid-19 and Self-Reported Adverse Post-Vaccination Events in Mbuji-Mayi, DR Congo.Infection and drug resistance · 2025Article
- Countering the threatening surge in SARS-CoV-2 variants in China and its possible global implications: stocktaking in the ongoing FISU and the Asian Games vigilance.Annals of medicine and surgery (2012) · 2024Article
- Newer emerging SARS-COV2 variant: Omicron EG.5.Annals of medicine and surgery (2012) · 2023Article
- COVID-19 vaccines and their underbelly: Are we going the right way?Health science reports · 2023Article
- General publics' perception toward COVID-19 vaccines in Afghanistan, 2021.Human vaccines & immunotherapeutics · 2023Article
- Observational
- Atypical follicular hyperplasia with light chain-restricted germinal centers after COVID-19 booster: a diagnostic pitfall.Virchows Archiv : an international journal of pathology · 2023Article
- Knowledge and willingness to receive a COVID-19 vaccine: a survey from Anhui Province, China.Human vaccines & immunotherapeutics · 2022Article
- COVID-19 Vaccines Adverse Reactions Reported to the Pharmacovigilance Unit of Beira Interior in Portugal.Journal of clinical medicine · 2022Article
- Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future.IJID regions · 2022Article
- Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile.Vaccines · 2022Article
- Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six Southeast Asian countries.Tropical medicine and health · 2022Article
- Reactogenicity to COVID-19 vaccination in the United States of America.Clinical and experimental vaccine research · 2022Article
- Safety surveillance and challenges in accelerated COVID-19 vaccine development.Therapeutic advances in drug safety · 2022Review
- Perception towards vaccine effectiveness in controlling COVID-19 spread in rural and urban communities: A global survey.Frontiers in public health · 2022Article
- Reintroduction of Post-Baccalaureate Doctor of Pharmacy (PharmD, Post-Bac) Program in Nepal: Exploration of the Obstacles and Solutions to Move Forward.Advances in medical education and practice · 2022Article
- Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.PLoS neglected tropical diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 7 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-2021, has caused enormous damage to health and lives globally. The urgent public health need has led to the development of vaccines against COVID-19 in record-breaking time. The COVID-19 vaccines have been widely rolled out for the masses by many countries following approval for emergency use by the World Health Organization and regulatory agencies in many countries. In addition, several COVID-19 vaccine candidates are undergoing clinical trials. However, myths, fears, rumors, and misconceptions persist, particularly in regard to adverse events. In this commentary, we describe the adverse events associated with COVID-19 vaccines and discuss why it is essential to have a functional adverse event monitoring system in this context.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.